Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntelliAM AI Regulatory News (INT.PL)

Share Price Information for IntelliAM AI (INT.PL)

Share Price is delayed by 15 minutes
Get Live Data
80.00    0.00 (0.00%)
Bid:
70.00
Ask:
90.00
Spread: 20.00 (28.571%)
Market Cap: £15.68m
INT.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday IntelliAM AI Share Chart

Annual Financial Report

25 Sep 2024 07:00

RNS Number : 5214F
IntelliAM AI PLC
25 September 2024
 

25 September 2024

IntelliAM AI plc("IntelliAM" or the "Company")Audited results FY24

 

IntelliAM AI plc (AQSE: INT), the software company leveraging the power of AI and machine learning in the manufacturing industry announces its audited results for the year ended 31 March 2024 (FY24), which are set out below. The reporting period covers the period from incorporation on 10 July 2023 until 31st March 2024 and prior to its listing on the Aquis exchange on 3 July 2024 and its acquisition of 53 Degrees North Engineering Ltd (53DN) on 4 July 2024.

 

Future reporting periods will include the financial performance of 53DN. As per the admission document, dated 26 June 2024 a copy of which is available at https://intelliam.ai/reports-presentations/, the unaudited revenue of 53DN, which is now the Group's Consulting division, for the year to 31st March 24 was £2,776,253 and a post- tax profit of £649,317.

 

Since listing on the Aquis Exchange in July 2024 and raising gross proceeds of £5.1m, the Company is pleased to have reported ongoing momentum in both divisions, with the following highlights:

· DIF Lighthouse Funding Award of around £263,000 for a research project to be

completed in the Company's current financial year;

· A significant extension to an existing agreement with a global leader in beverage alcohol across more than 35 maltings sites in the UK worth a minimum of at least

£100,000 per annum over the next two years; and

· Contracts for 3 large Hovis sites for the Company's consultancy reliability services and project services for all Hovis manufacturing sites worth in excess of £100,000 over a 12-month period.

The Company intends to announce interim results for the 6 months to 30 September 2024 in mid-November.

 

 

Enquiries:

IntelliAM AI plc

Tom Clayton, Chief Executive Officer Daud Khan, Chief Financial Officer

+44 114 299 5007

Oberon Capital - AQSE Corporate Adviser and Broker

Adam Pollock Mike Seabrook Jessica Cave

+44 203 179 5300

Square1 Consulting - Financial PR

David Bick

+44 207 929 5599

+44 7831 381201

 

 

Below is an excerpt of the accounts, the full report and accounts are available at the following link https://intelliam.ai/reports-presentations/

 

 

INTELLIAM AI PLC

(FORMERLY KNOWN AS INTELLIAM AI LIMITED) PROFIT AND LOSS ACCOUNT

FOR THE PERIOD ENDED 31 MARCH 2024

 

 

Period from 10 July

2023 to

31 March

2024

Notes £

 

Turnover 3 105,510

 

Administrative expenses (335,552)

 

Loss before taxation (230,042)

 

Tax on loss 6 31,580

 

Loss for the financial period (198,462)

 

 

The profit and loss account has been prepared on the basis that all operations are continuing operations.

INTELLIAM AI PLC

(FORMERLY KNOWN AS INTELLIAM AI LIMITED) BALANCE SHEET

AS AT 31 MARCH 2024

 

 

 

Fixed assets

 

 

Notes

 

 

£

2024

£

 

Intangible assets

8

270,000

Tangible assets

9

4,687

 

Current assets

274,687

Debtors

10

76,347

Cash at bank and in hand

90,677

167,024

Creditors: amounts falling due within one year

11

(176,764)

Net current liabilities

(9,740)

Total assets less current liabilities

264,947

Provisions for deferred tax

7

31,580

Net assets

296,527

 

Capital and reserves

Called up share capital

 

 

12

 

 

313,723

Share premium account

13

181,266

Profit and loss reserves

13

(198,462)

Total equity

296,527

 

 

 

INTELLIAM AI PLC (FORMERLY KNOWN AS INTELLIAM AI LIMITED) STATEMENT OF CHANGES IN EQUITY

FOR THE PERIOD ENDED 31 MARCH 2024

 

 

Share capital
Share 
Premium 
account
Profit and loss reservesTotal

Notes

£

£

£

£

Balance at 10 July 2023

-

-

-

-

Period ended 31 March 2024:

Loss and total comprehensive income

 

-

 

-

 

(198,462)

 

(198,462)

Issue of share capital

12

313,723

181,266

-

494,989

Balance at 31 March 2024

313,723

181,266

(198,462)

296,527

INTELLIAM AI PLC

(FORMERLY KNOWN AS INTELLIAM AI LIMITED) STATEMENT OF CASH FLOWS

FOR THE PERIOD ENDED 31 MARCH 2024

 

 

Notes

 

 

£

 

2024

£

Cash flows from operating activities

Cash absorbed by operations

 

18

 

(87,057)

Investing activities

Purchase of tangible fixed assets

9

(4,766)

Net cash used in investing activities

(4,766)

Financing activities

Proceeds from issue of shares

12

 182,500

Net cash generated from/(used in) financing activities

182,500

Net increase in cash and cash equivalents

90,677

Cash and cash equivalents at beginning of period

-

Cash and cash equivalents at end of period

90,677

 

 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXEAFNLASALEAA
12
Date   Source Headline
8th Jul 20267:00 amRNSNew Customer Wins
7th Jul 20267:07 amRNSFundraising to augment growth in US operations
6th Jul 20267:30 amRNSLaunch of Investor Hub
20th May 20267:00 amRNSUS Expansion and CRO Appointment
16th Apr 20267:00 amRNSTrading Update
1st Apr 20267:00 amRNSAcquisition of RBM Lubrications
19th Mar 20267:00 amRNSAppointment of Corporate Adviser and Broker
6th Jan 20267:00 amRNSOrders from New Customer in Frozen Food Vertical
29th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
10th Dec 20258:17 amRNSHolding(s) in Company
2nd Dec 20258:38 amRNSResult of Oversubscribed WRAP Retail Offer
25th Nov 20257:05 amRNSContract
25th Nov 20257:00 amRNSHalf-year Financial Report
24th Nov 202512:35 pmRNSWRAP Retail Offer
24th Nov 202512:30 pmRNSPlacing and Retail Offer
4th Nov 20257:00 amRNSFirst Half Trading Statement
27th Oct 20257:35 amRNSMove from Access to Apex segment
3rd Oct 20253:45 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSContract
24th Sep 20257:00 amRNSContract
12th Sep 20257:00 amRNS-RManufacturing Tech Award 2025
9th Sep 202512:33 pmRNSResult of Annual General Meeting
4th Sep 20257:00 amRNSDirectorate Change
12th Aug 20257:00 amRNSAnnual Financial Report
8th Aug 20253:00 pmRNSHolding(s) in Company
25th Jul 20257:00 amRNS-RAppointment of Vice President of Sales
7th Jul 20257:00 amRNSFinal Results
3rd Jul 20257:00 amRNSStrategic Partnership Agreement with CTC in USA
2nd Jul 20257:00 amRNSContract
1st Jul 20257:00 amRNSDirectorate Change
27th May 20257:00 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSTrading Update
2nd May 20257:00 amRNSDirectorate Change
26th Mar 20257:00 amRNS-RSenior Management Team Strengthened
20th Mar 20252:25 pmRNSDirector/PDMR Shareholding
24th Feb 20251:00 pmRNSDeath of a Non-Executive Director
13th Jan 20257:00 amRNSDirectorate Change
18th Dec 20243:57 pmRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSDirector/PDMR Shareholding
16th Dec 20247:00 amRNSDirector/PDMR Shareholding
12th Dec 20244:51 pmRNSDirector/PDMR Shareholding
11th Dec 20247:00 amRNSLetter of Intent Signed
9th Dec 20247:00 amRNSHalf-year Report
6th Nov 20241:13 pmRNSResult of Annual General Meeting
10th Oct 20243:30 pmRNSPosting of Annual Report and Notice of AGM
25th Sep 20247:00 amRNSAnnual Financial Report
16th Sep 20247:00 amRNSContract
7th Aug 20247:00 amRNSContract
11th Jul 20247:00 amRNSContract
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.